Literature DB >> 2111668

[Surgery of endomyocardial fibrosis. Apropos of 32 cases].

C Dubost1, C Chapelon, A Deloche, J C Piette, S Chauvaud, J N Fabiani, A Carpentier.   

Abstract

From 1971 to 1984, 32 patients with endomyocardial fibrosis (EMF) were treated by endocardial resection (decortication) and valve replacement. The population consisted in 20 men and 12 women (age ranged from 8 to 64); 19 patients were european and 13 african. All were symptomatic, 78 p. 100 in stages III or IV of the NYHA. Hypereosinophilia was detected in 21 patients and its cause was determined in 11 cases. Cardiac involvement was biventricular in 22 patients and monoventricular in 10 patients. Six patients died in the immediate postoperative period and 6 late deaths were observed, owing to extracardiac causes in 4. There were no recurrence of EMF. Despite a high mortality rate, the authors suggest that all symptomatic EMF should benefit from endocardial resection.

Entities:  

Mesh:

Year:  1990        PMID: 2111668

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  4 in total

Review 1.  Forgotten cardiovascular diseases in Africa.

Authors:  Karen Sliwa; Ana Olga Mocumbi
Journal:  Clin Res Cardiol       Date:  2009-12-11       Impact factor: 5.460

Review 2.  The challenges of cardiac surgery for African children.

Authors:  Ana O H Mocumbi
Journal:  Cardiovasc J Afr       Date:  2012-04       Impact factor: 1.167

Review 3.  Endomyocardial fibrosis: A form of endemic restrictive cardiomyopathy.

Authors:  Ana Olga Mocumbi
Journal:  Glob Cardiol Sci Pract       Date:  2012-07-17

4.  A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation.

Authors:  Gernot Wagner; Markus Haumer; Gerhard Poelzl; Dominik Wiedemann; Andreas Kliegel; Robert Ullrich; Gerald Gartlehner; Andreas Zuckermann; Ludwig Müller; Harald Mayr; Deddo Moertl
Journal:  BMC Cardiovasc Disord       Date:  2019-12-19       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.